Background: Recent data associate eosinophilic esophagitis (EoE) with IgG4 rather
not reliably identify food triggers. 4, 5 Accordingly, an anti-IgE monoclonal antibody (omalizumab) does not improve symptoms or induce histologic remission. 6 Recent data suggest an association between elevated levels of IgG4 and EoE. 7 Clayton et al 6 showed that adult EoE patients had increased levels of IgG4 in esophageal tissue. Furthermore, when food triggers were eliminated, total and food-specific IgG4 levels in the esophagus decreased in adult patients who achieved histologic resolution (diet responders) but not in diet nonresponders. 8 Though these studies provide preliminary evidence for a role of IgG4 in adult EoE, the applicability of these findings to pediatric EoE, as well the functional significance, have not been determined. Notably, high
IgG4 levels are generated following allergen immunotherapy and in beekeepers, two scenarios in which individuals are exposed to high levels of antigen. IgG4 is thought to be a neutralizing antibody because it binds weakly to Fcc receptors, does not fix complement or activate antibody-dependent cellular cytotoxicity, and undergoes Fab-arm exchange, which limits its ability to cross-link receptors and form immune complexes. 9 It remains unknown whether alterations in IgG4 levels occur in pediatric EoE and whether IgG4 correlates with specific disease features; IgG4 may have a pathogenic role in EoE or may simply be a readout of a suppressive humoral antibody response to chronic antigen exposure.
Herein, we hypothesized that (i) esophageal IgG4 levels are elevated in pediatric subjects with EoE, (ii) IgG4 levels correlate with disease activity as defined by esophageal eosinophil levels and histologic scores, (iii) IgG4 levels correlate with esophageal mRNA expression of cytokines known to influence class switching to and production of IgG4, (iv) IgG4 levels correlate with a subset of the EoE transcriptome, and (v) IgG4 is locally produced in the esophagus.
| MATERIALS AND METHODS

| Study design and subject selection
A case-control study was conducted with samples from pediatric subjects with EoE (N = 17) and non-EoE control subjects (N = 19).
Subjects were matched for age and gender when possible and were selected without regard to atopic status. All subjects were <18 years of age and of Caucasian descent. Subjects with EoE had peak eosi- 
| Tissue immunoglobulin quantitation
| Histologic evaluation
Distal esophageal biopsies obtained for diagnosis were fixed in formalin, processed into paraffin blocks from which 5-micron sections were cut, and stained with hematoxylin and eosin. The slides were scored using the EoE histology scoring system (EoEHSS) 10 by a pathologist (MHC) who was blinded to all subject characteristics; these biopsies were obtained from the same endoscopy as the research biopsies used for tissue immunoglobulin quantitation.
| RNA extraction and reverse transcription
Total RNA was extracted from esophageal biopsy specimens collected in RNAlater using the miRNeasy RNA Extraction Kit (217004, Qiagen, Germantown, MD), according to the manufacturer's protocol. Similarly, these biopsies were obtained from the same endoscopy as the research biopsies used for tissue immunoglobulin quantitation. RNA (500 ng) was reverse transcribed using ProtoScript calculated from the EDP as previously described. 12 Of note, the total EoE score is inversely correlated with disease activity.
| Transcriptomic analysis
| Statistical considerations
Demographic characteristics between subjects with EoE and nonEoE control subjects were compared using the 5.3-12.2] ; N = 19) or gender was observed between groups; both groups had a male predominance (94% vs 79%, respectively) (Table S1 ). There was no significant difference in atopic status between the two groups (94% vs 74%). There was no significant difference in proton pump inhibitor use between the two groups (65% and 84%). There was no significant difference in combined atopic status and proton pump inhibitor use between the two groups (49% and 52%). In subjects with EoE, therapies for the treatment of EoE included swallowed topical steroids alone (either fluticasone propionate or budesonide), diet modification alone (elemental diet, elimination diet, and/or food trial), or both swallowed steroids and diet modification. One patient was untreated.
| Esophageal tissue immunoglobulin quantitation
Increases of IgG subclasses, as well as IgA and IgM, were seen in subjects with EoE relative to controls ( Figure S1B ) and tissue IgG4 content. There were no significant differences in tissue IgG4 levels among subjects with EoE on different therapies (P = .1349).
| Esophageal tissue IgG4 content and histologic features of EoE
Tissue IgG4 levels positively correlated with peak eosinophil count (Spearman q = .76; P = .0006) of a corresponding esophageal biopsy taken at the same endoscopy in subjects with EoE ( Figure 2A ), which was the strongest correlation of all the immunoglobulins (Table S2) .
Furthermore, tissue IgG4 levels correlated with mean histologic grade (q = .74; P = .0011; Figure 2B ) and stage (q = .61; P = .0112; Figure 2C ) scores in subjects with EoE.
Focusing on each of the histologic features, tissue IgG4 levels correlated most substantially with the grade score of basal zone hyperplasia (q = .78; P = .0004); significant correlations were also seen with the grade scores of eosinophilic inflammation (q = .51; P = .0431) and surface epithelial alteration (q = .50; P = .0408) and the stage scores of basal zone hyperplasia (q = .64; P = .0070), eosinophilic inflammation (q = .49; P = .0468), eosinophil surface layering (q = .50; P = .0448), dilated intercellular spaces (q = À.49; P = .0490), and surface epithelial alteration (q = .49; P = .0479) (Figure 2D) . Biopsies of 11 out of 17 subjects with EoE included lamina propria; in this subset, tissue IgG4 levels did not correlate with the grade or stage scores of lamina propria fibrosis (respectively, q = .22; P = .5160 and q = .23; P = .5368).
In non-EoE control subjects, there were no significant correlations between tissue IgG4 levels and peak eosinophil count (q = À.07; P = .7612), mean histologic grade score (q = À.29; P = .2474), or mean histologic stage score (q = À.07; P = .7754).
| Esophageal tissue IgG4 content and cytokine mRNA expression in the esophageal mucosa
Tissue IgG4 protein levels correlated with esophageal IL4 (q = .51; P = .0366) ( Figure 3A) , IL13 (q = 0.67; P = .0040) ( Figure 3B ), and IL10 (q = .49; P = .0465) ( Figure 3C ) mRNA expression levels in subjects with EoE. In contrast, there was no correlation between tissue IgG4 levels and transforming growth factor beta (TGFB1) mRNA expression levels ( Figure 3D ).
| Expression of IgG4 heavy chain mRNA in the esophageal mucosa
A large variation in the IGHG4 mRNA levels was observed in esophageal biopsies. However, IGHG4 mRNA was present in the esophageal mucosa and was increased in subjects with EoE compared with control individuals (P = .0413) ( Figure S2 ). Representative IGHG4 PCR products were sequenced to confirm their identities compared to the corresponding GenBank IGHG4 sequence (AJ294733.1).
Tissue IgG4 levels correlated with esophageal IGHG4 mRNA expression levels (q = .56; P = .0203) in subjects with EoE (Figure 4A ). Esophageal IGHG4 mRNA expression levels correlated with IL10 mRNA expression levels (q = .57; P = .0191) ( Figure 4B ), but not IL4, IL13, and TGFB1 mRNA expression levels in subjects with EoE ( Figure S3A-C) . In non-EoE control individuals, esophageal IGHG4 mRNA expression levels did not correlate with IL10 mRNA expression levels ( Figure S4 ).
| Esophageal tissue IgG4 content and a diagnostic subset of the EoE transcriptome
Tissue IgG4 levels correlated with total scores from the EoE Diagnostic Panel, a set of 96 genes expressed in the esophagus (q = À.71; P = .0021) ( Figure S5 ). 12 Nonparametric correlations identified 62 genes with expression levels that significantly correlated with tissue IgG4 levels (following false discovery rate-corrected P < .05). There was a diverse set of functional categories among these 62 genes, including cell adhesion (4 of 5 genes), chemokines and cytokines (5 of 6 genes), epithelial barrier (11 of 12 genes), inflammation (16 of 22 genes), ion channels (4 of 4 genes), and proliferation (6 of 7 genes) ( Figure 5 ). Of note, levels of mast cell-specific transcripts (eg, CPA3) did not correlate with IgG4 levels (P > .0647).
T 
F I G U R E 2 Esophageal tissue IgG4 content and histologic features of eosinophilic esophagitis (EoE)
. A, Correlation between esophageal peak eosinophil count (peak eosinophil count/HPF) and esophageal tissue homogenate IgG4 content (mg IgG4 per gram of total protein) in subjects with EoE. Each data point represents the mean IgG4 measurement from an individual distal biopsy from 17 biologically independent subjects. The lines represent the standard deviation for each data point. B, Correlation between histologic grade (as a fraction of the total histologic score) and esophageal tissue homogenate IgG4 content (mg IgG4 per gram of total protein) in subjects with EoE. C, Correlation between histologic stage (as a fraction of the total histologic score) and esophageal tissue homogenate IgG4 content (mg IgG4 per gram of total protein) in subjects with EoE. D, A heat map was generated demonstrating the degree of correlation between esophageal tissue IgG4 content and each of the histologic features by grade and stage. Red indicates a higher degree of correlation (closer to Spearman q of 1.0) and blue represents a lower degree of correlation (closer to a Spearman q of zero). The magnitude of the color change is proportional to the strength of the correlation. Eosinophil inflammation (EI) was evaluated using peak eosinophil counts obtained by counting eosinophils in the most densely inflamed HPF. Additional features were basal zone hyperplasia (BZH): >15% of the total epithelial thickness; eosinophil abscess (EA): solid mass of intraepithelial eosinophils; eosinophil surface layering (SL): linear alignment of eosinophils parallel to the epithelial surface; dilated intercellular spaces (DIS): spaces around squamous epithelial cells that exhibit intercellular bridges; surface epithelial alteration (SEA): surface epithelial cells that exhibit altered tinctorial properties, manifest as dark red staining, with or without intraepithelial eosinophils; dyskeratotic epithelial cells (DEC): individual cells with deeply eosinophilic cytoplasm and hyperchromatic nuclei; lamina propria fibrosis (LPF): thickened connective tissue fibers in the lamina propria (v) esophageal IgG4 protein levels strongly correlate with multiple components of the disease as assessed by transcriptome profiling, although no correlation was seen with transcript markers of mast cell tissue burden. 13 Collectively, these findings extend prior studies focused on IgG4 in adult EoE to the pediatric population and provide deeper understanding of the potential significance and regulation of IgG4. In particular, these data show that IgG4 is a relevant feature of the disease rather than an epiphenomenon associated with a subset of patients, is closely related to esophageal eosinophil counts and degree of basal zone hyperplasia, and is likely produced locally, at least in part.
Whereas increases in IgA, IgM, and the other IgG subclasses were detected, the greatest change observed was in IgG4. Of all the immunoglobulins, IgG4 had the strongest correlation with esophageal eosinophil numbers. These data suggest that the local immunoglobu- 20, 21 and T regulatory cells in EoE, 22, 23 including a study demonstrating local immunoglobulin class switching to IgE and IgE production in the esophageal mucosa of EoE patients, 24 we sought to provide evidence of local IgG4 production.
Indeed, these data demonstrate that local IGHG4 mRNA expression IgG4 studies may help clarify whether food-specific serum IgG4 levels may be a noninvasive method for the identification of offending foods.
The mechanistic basis for the association of IgG4 with EoE is still enigmatic and is a question that future studies must address.
In summary, esophageal IgG4 levels are elevated in pediatric EoE and correlate with disease activity as assessed by esophageal eosinophil counts, histologic scores, and transcriptomic features of EoE, providing evidence that tissue IgG4 level is a biomarker of disease activity, is closely related to type 2 immunity and T regulatory cytokines, especially IL10, and is likely produced locally. 
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